Meeder Asset Management Inc. Makes New Investment in Maximus, Inc. (NYSE:MMS)

Meeder Asset Management Inc. purchased a new stake in shares of Maximus, Inc. (NYSE:MMS) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 18,849 shares of the health services provider’s stock, valued at approximately $1,407,000.

Other hedge funds have also modified their holdings of the company. Arrowstreet Capital Limited Partnership grew its stake in Maximus by 108.5% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 84,309 shares of the health services provider’s stock valued at $6,294,000 after purchasing an additional 43,864 shares in the last quarter. Pictet Asset Management Holding SA increased its holdings in Maximus by 8.6% in the fourth quarter. Pictet Asset Management Holding SA now owns 8,563 shares of the health services provider’s stock worth $639,000 after buying an additional 676 shares during the last quarter. New Age Alpha Advisors LLC acquired a new position in Maximus in the fourth quarter worth approximately $3,345,000. Norges Bank bought a new position in Maximus during the fourth quarter valued at approximately $71,443,000. Finally, JPMorgan Chase & Co. lifted its stake in Maximus by 46.0% in the fourth quarter. JPMorgan Chase & Co. now owns 326,748 shares of the health services provider’s stock valued at $24,392,000 after acquiring an additional 102,982 shares during the last quarter. 97.21% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Jan Madsen sold 2,439 shares of Maximus stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the sale, the director now directly owns 18,097 shares of the company’s stock, valued at $1,225,347.87. This trade represents a 11.88 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Ilene R. Baylinson sold 14,500 shares of the business’s stock in a transaction dated Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the transaction, the insider now owns 2,512 shares in the company, valued at $171,167.68. This represents a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.

Analyst Ratings Changes

MMS has been the topic of several analyst reports. StockNews.com lowered shares of Maximus from a “buy” rating to a “hold” rating in a research note on Friday, February 14th. Raymond James raised shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price on the stock in a research report on Thursday, January 2nd.

Maximus Stock Up 0.1 %

Shares of MMS stock opened at $68.18 on Monday. The company has a market capitalization of $3.86 billion, a price-to-earnings ratio of 14.66 and a beta of 0.71. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. The stock’s 50 day simple moving average is $70.00 and its 200 day simple moving average is $77.78. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $93.97.

Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, beating analysts’ consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. As a group, research analysts predict that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Saturday, February 15th were given a dividend of $0.30 per share. The ex-dividend date was Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.76%. Maximus’s dividend payout ratio is presently 25.81%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.